22-37765832-G-GC
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001039141.3(TRIOBP):c.6472+15_6472+16insC variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00595 in 1,585,328 control chromosomes in the GnomAD database, including 47 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0045 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0061 ( 43 hom. )
Consequence
TRIOBP
NM_001039141.3 intron
NM_001039141.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.07
Publications
1 publications found
Genes affected
TRIOBP (HGNC:17009): (TRIO and F-actin binding protein) This gene encodes a protein with an N-terminal pleckstrin homology domain and a C-terminal coiled-coil region. The protein interacts with trio, which is involved with neural tissue development and controlling actin cytoskeleton organization, cell motility and cell growth. The protein also associates with F-actin and stabilizes F-actin structures. Mutations in this gene have been associated with a form of autosomal recessive nonsyndromic deafness. Multiple alternatively spliced transcript variants that would encode different isoforms have been found for this gene, however some transcripts may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Nov 2008]
TRIOBP Gene-Disease associations (from GenCC):
- autosomal recessive nonsyndromic hearing loss 28Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia
- hearing loss, autosomal recessiveInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 22-37765832-G-GC is Benign according to our data. Variant chr22-37765832-G-GC is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257224.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00447 (676/151322) while in subpopulation AMR AF = 0.00794 (121/15236). AF 95% confidence interval is 0.00679. There are 4 homozygotes in GnomAd4. There are 319 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TRIOBP | ENST00000644935.1 | c.6472+15_6472+16insC | intron_variant | Intron 18 of 23 | NM_001039141.3 | ENSP00000496394.1 | ||||
| TRIOBP | ENST00000403663.6 | c.1333+15_1333+16insC | intron_variant | Intron 8 of 13 | 1 | ENSP00000386026.2 | ||||
| TRIOBP | ENST00000344404.10 | n.*5955+15_*5955+16insC | intron_variant | Intron 16 of 21 | 2 | ENSP00000340312.6 |
Frequencies
GnomAD3 genomes AF: 0.00447 AC: 676AN: 151204Hom.: 4 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
676
AN:
151204
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00440 AC: 890AN: 202474 AF XY: 0.00428 show subpopulations
GnomAD2 exomes
AF:
AC:
890
AN:
202474
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00611 AC: 8755AN: 1434006Hom.: 43 Cov.: 35 AF XY: 0.00601 AC XY: 4279AN XY: 711668 show subpopulations
GnomAD4 exome
AF:
AC:
8755
AN:
1434006
Hom.:
Cov.:
35
AF XY:
AC XY:
4279
AN XY:
711668
show subpopulations
African (AFR)
AF:
AC:
40
AN:
33100
American (AMR)
AF:
AC:
161
AN:
42466
Ashkenazi Jewish (ASJ)
AF:
AC:
364
AN:
25708
East Asian (EAS)
AF:
AC:
0
AN:
38894
South Asian (SAS)
AF:
AC:
168
AN:
83380
European-Finnish (FIN)
AF:
AC:
27
AN:
43824
Middle Eastern (MID)
AF:
AC:
34
AN:
5002
European-Non Finnish (NFE)
AF:
AC:
7603
AN:
1102208
Other (OTH)
AF:
AC:
358
AN:
59424
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
480
961
1441
1922
2402
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
308
616
924
1232
1540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00447 AC: 676AN: 151322Hom.: 4 Cov.: 32 AF XY: 0.00431 AC XY: 319AN XY: 73964 show subpopulations
GnomAD4 genome
AF:
AC:
676
AN:
151322
Hom.:
Cov.:
32
AF XY:
AC XY:
319
AN XY:
73964
show subpopulations
African (AFR)
AF:
AC:
59
AN:
41342
American (AMR)
AF:
AC:
121
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
AC:
52
AN:
3440
East Asian (EAS)
AF:
AC:
0
AN:
5142
South Asian (SAS)
AF:
AC:
4
AN:
4770
European-Finnish (FIN)
AF:
AC:
5
AN:
10538
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
420
AN:
67536
Other (OTH)
AF:
AC:
14
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
33
67
100
134
167
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Jun 22, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not provided Benign:2
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Jul 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
TRIOBP: BS2
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.